---
figid: PMC5739070__nihms911839f3
figtitle: Optic Pathway Gliomas in Neurofibromatosis Type 1
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC5739070
filename: nihms911839f3.jpg
figlink: /pmc/articles/PMC5739070/figure/F3/
number: F3
caption: The NF1 protein, neurofibromin, functions as a GTPase-activating protein
  (GAP) for p21-RAS, accelerating its conversion from an active RAS-GTP bound molecule
  to an inactive RAS-GDP bound form. RAS can be activated by G protein-coupled receptors
  (GPCRs), including chemokine receptors, and by receptor tyrosine kinase (RTK) binding
  of growth factors, like epidermal growth factor. Active RAS controls multiple downstream
  signaling pathways, engaging MEK and AKT through kinase intermediates, to activate
  ERK and the mechanistic target of rapamycin (mTOR) complex, respectively. In addition,
  RAS activation suppresses cyclic AMP (cAMP) generation, important for central nervous
  system neuron survival.
papertitle: Optic Pathway Gliomas in Neurofibromatosis Type 1.
reftext: Cynthia J. Campen, et al. J Child Neurol. ;33(1):73-81.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9220905
figid_alias: PMC5739070__F3
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC5739070__F3
ndex: 8cb23795-dedd-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5739070__nihms911839f3.html
  '@type': Dataset
  description: The NF1 protein, neurofibromin, functions as a GTPase-activating protein
    (GAP) for p21-RAS, accelerating its conversion from an active RAS-GTP bound molecule
    to an inactive RAS-GDP bound form. RAS can be activated by G protein-coupled receptors
    (GPCRs), including chemokine receptors, and by receptor tyrosine kinase (RTK)
    binding of growth factors, like epidermal growth factor. Active RAS controls multiple
    downstream signaling pathways, engaging MEK and AKT through kinase intermediates,
    to activate ERK and the mechanistic target of rapamycin (mTOR) complex, respectively.
    In addition, RAS activation suppresses cyclic AMP (cAMP) generation, important
    for central nervous system neuron survival.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Hras
  - Kras
  - Rem1
  - Nf2
  - Zhx2
  - pk
  - Mdk
  - Akt1
  - Mtor
  - Yap1
  - Ptk2
  - Ephb2
  - Mapk1
  - Rac1
  - Pik3r1
  - Src
  - MTG1
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - YAP1
  - PTK2
  - EPHB2
  - MAPK1
  - MAPK3
  - RAC1
  - RNASE1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SRC
  - FGR
  - FYN
  - YES1
  - Sorafenib
  - Imatinib
  - Sunitinib
  - Lapatinib
  - Axitinib
  - Verteporfin
  - Crizotinib H
  - GRD
---
